Source: Xconomy

CytoBioscience: CytoBioScience Raises $1.5M for "Intended Merger," Document Says

San Antonio - CytoBioScience, a bioscience company that canceled plans to merge with a publicly traded business last year, may have new merger plans. The San Antonio-based business raised a $1.53 million equity round of funding, according to a document filed with the SEC, which states that the funds are being raised in connection with an [...]

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
James Garvin's photo - CEO of  CytoBioscience

CEO

James Garvin

CEO Approval Rating

79/100

Read more